Biology of the Natriuretic Peptides

American Journal of Cardiology

Volumn 101, Issue 3 SUPPL., 2008, Pages

  Martinez Rumayor, Abelardo ^a   Richards, A Mark ^b   Burnett, John C ^c   Januzzi Jr , James L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BIOLOGY; HEART FAILURE; HORMONE RELEASE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR SYSTEM; HOMEOSTASIS; HUMANS; NATRIURETIC PEPTIDES;

EID: 38649114063     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.012     Document Type: Article

References (72)

1. Patel J.B., Valencik M.L., Pritchett A.M., Burnett Jr. J.C., McDonald J.A., and Redfield M.M. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload. Am J Physiol Heart Circ Physiol 289 (2005) H777-H784
2. Tamura N., Ogawa Y., Yasoda A., Itoh H., Saito Y., and Nakao K. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J Mol Cell Cardiol 28 (1996) 1811-1815
3. Best P.J., Burnett J.C., Wilson S.H., Holmes Jr. D.R., and Lerman A. Dendroaspis natriuretic peptide relaxes isolated human arteries and veins. Cardiovasc Res 55 (2002) 375-384
4. Chen H.H., Lainchbury J.G., and Burnett Jr. J.C. Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide dendroaspis natriuretic peptide. J Am Coll Cardiol 40 (2002) 1186-1191
5. Gao Y.L., Xin H.N., Feng Y., and Fan J.W. Human plasma DNP level after severe brain injury. Chin J Traumatol 9 (2006) 223-227
6. Giuliani I., Rieunier F., Larue C., Delagneau J.F., Granier C., Pau B., Ferriere M., Saussine M., Cristol J.P., Dupuy A.M., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 52 (2006) 1054-1061
7. Johns D.G., Ao Z., Heidrich B.J., Hunsberger G.E., Graham T., Payne L., Elshourbagy N., Lu Q., Aiyar N., and Douglas S.A. Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor. Biochem Biophys Res Commun 358 (2007) 145-149
8. Lainchbury J.G., Lisy O., Burnett Jr. J.C., Meyer D.M., and Redfield M.M. Actions of a novel synthetic natriuretic peptide on hemodynamics and ventricular function in the dog. Am J Physiol Regul Integr Comp Physiol 282 (2002) R993-R998
9. Lisy O., Lainchbury J.G., Leskinen H., and Burnett Jr. J.C. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure. Hypertension 37 (2001) 1089-1094
10. Singh G., Kuc R.E., Maguire J.J., Fidock M., and Davenport A.P. Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure. Circ Res 99 (2006) 183-190
11. 125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation. Br J Pharmacol 149 (2006) 838-844
12. St. Pierre L., Flight S., Masci P.P., Hanchard K.J., Lewis R.J., Alewood P.F., de Jersey J., and Lavin M.F. Cloning and characterisation of natriuretic peptides from the venom glands of Australian elapids. Biochimie 88 (2006) 1923-1931
13. Wei C.M., Kim C.H., Miller V.M., and Burnett Jr. J.C. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest 92 (1993) 2048-2052
14. +-ATPase of proximal tubules is an effector for urodilatin and atrial natriuretic peptide. Biochim Biophys Acta 1660 (2004) 93-98
15. Meyer M., Richter R., and Forssmann W.G. Urodilatin, a natriuretic peptide with clinical implications. Eur J Med Res 3 (1998) 103-110
16. Mitrovic V., Luss H., Nitsche K., Forssmann K., Maronde E., Fricke K., Forssmann W.G., and Meyer M. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. Am Heart J 150 (2005) 1239.e1-1239.e8
17. Mitrovic V., Seferovic P.M., Simeunovic D., Ristic A.D., Miric M., Moiseyev V.S., Kobalava Z., Nitsche K., Forssmann W.G., Luss H., and Meyer M. Haemodynamic and clinical effects of ularitide in decompensated heart failure. Eur Heart J 27 (2006) 2823-2832
18. Gunning M., and Brenner B.M. Urodilatin: a potent natriuretic peptide of renal origin. Curr Opin Nephrol Hypertens 2 (1993) 857-862
19. iα protein/MAP kinase/PI3-kinase/AKT pathways. Am J Physiol Heart Circ Physiol 291 (2006) H3144-H3153
20. Huntley B.K., Sandberg S.M., Noser J.A., Cataliotti A., Redfield M.M., Matsuda Y., and Burnett Jr. J.C. BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors. J Cell Physiol 209 (2006) 943-949
21. Rosenzweig A., and Seidman C.E. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60 (1991) 229-255
22. Farrell A.P., and Olson K.R. Cardiac natriuretic peptides: a physiological lineage of cardioprotective hormones?. Physiol Biochem Zool 73 (2000) 1-11
23. Takei Y. Structural and functional evolution of the natriuretic peptide system in vertebrates. Int Rev Cytol 194 (2000) 1-66
24. Loretz C.A., and Pollina C. Natriuretic peptides in fish physiology. Comp Biochem Physiol A Mol Integr Physiol 125 (2000) 169-187
25. Fowkes R.C., and McArdle C.A. C-type natriuretic peptide: an important neuroendocrine regulator?. Trends Endocrinol Metab 11 (2000) 333-338
26. Liu Z.L., Wiedmeyer C.E., Sisson D.D., and Solter P.F. Cloning and characterization of feline brain natriuretic peptide. Gene 292 (2002) 183-190
27. Takei Y. Does the natriuretic peptide system exist throughout the animal and plant kingdom?. Comp Biochem Physiol B Biochem Mol Biol 129 (2001) 559-573
28. Suzuki R., Takahashi A., Hazon N., and Takei Y. Isolation of high-molecular-weight C-type natriuretic peptide from the heart of a cartilaginous fish (European dogfish, Scyliorhinus canicula). FEBS Lett 282 (1991) 321-325
29. Kawakoshi A., Hyodo S., Nozaki M., and Takei Y. Identification of a natriuretic peptide (NP) in cyclostomes (lamprey and hagfish): CNP-4 is the ancestral gene of the NP family. Gen Comp Endocrinol 148 (2006) 41-47
30. Inoue K., Naruse K., Yamagami S., Mitani H., Suzuki N., and Takei Y. Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system. Proc Natl Acad Sci U S A 100 (2003) 10079-10084
31. LaPointe M.C., Wu G., Garami M., Yang X.P., and Gardner D.G. Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes. Hypertension 27 (1996) 715-722
32. Tamura N., Ogawa Y., Chusho H., Nakamura K., Nakao K., Suda M., Kasahara M., Hashimoto R., Katsuura G., Mukoyama M., et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 97 (2000) 4239-4244
33. Ogawa Y., Tamura N., Chusho H., and Nakao K. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol 79 (2001) 723-729
34. Yamamoto K., Burnett Jr. J.C., and Redfield M.M. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am J Physiol 273 (1997) H2406-H2414
35. Sudoh T., Maekawa K., Kojima M., Minamino N., Kangawa K., and Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 159 (1989) 1427-1434
36. LaPointe M.C. Molecular regulation of the brain natriuretic peptide gene. Peptides 26 (2005) 944-956
37. Seilhamer J.J., Arfsten A., Miller J.A., Lundquist P., Scarborough R.M., Lewicki J.A., and Porter J.G. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun 165 (1989) 650-658
38. Mukoyama M., Nakao K., Saito Y., Ogawa Y., Hosoda K., Suga S., Shirakami G., Jougasaki M., and Imura H. Human brain natriuretic peptide, a novel cardiac hormone. Lancet 335 (1990) 801-802
39. Gerbes A.L., Dagnino L., Nguyen T., and Nemer M. Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metab 78 (1994) 1307-1311
40. Liang F., and Gardner D.G. Mechanical strain activates BNP gene transcription through a p38/NF-κB-dependent mechanism. J Clin Invest 104 (1999) 1603-1612
41. Pikkarainen S., Tokola H., Majalahti-Palviainen T., Kerkela R., Hautala N., Bhalla S.S., Charron F., Nemer M., Vuolteenaho O., and Ruskoaho H. GATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic program. J Biol Chem 278 (2003) 23807-23816
42. Cameron V.A., Rademaker M.T., Ellmers L.J., Espiner E.A., Nicholls M.G., and Richards A.M. Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. Endocrinology 141 (2000) 4690-4697
43. Goetze J.P., Christoffersen C., Perko M., Arendrup H., Rehfeld J.F., Kastrup J., and Nielsen L.B. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17 (2003) 1105-1107
44. He Q., Wang D., Yang X.P., Carretero O.A., and LaPointe M.C. Inducible regulation of human brain natriuretic peptide promoter in transgenic mice. Am J Physiol Heart Circ Physiol 280 (2001) H368-H376
45. He Q., and LaPointe M.C. Src and Rac mediate endothelin-1 and lysophosphatidic acid stimulation of the human brain natriuretic peptide promoter. Hypertension 37 (2001) 478-484
46. Pikkarainen S., Tokola H., Kerkela R., Majalahti-Palviainen T., Vuolteenaho O., and Ruskoaho H. Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors. J Biol Chem 278 (2003) 3969-3975
47. Wiese S., Breyer T., Dragu A., Wakili R., Burkard T., Schmidt-Schweda S., Fuchtbauer E.M., Dohrmann U., Beyersdorf F., Radicke D., and Holubarsch C.J. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102 (2000) 3074-3079
48. 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem 269 (1994) 26227-26233
49. Qi W., Mathisen P., Kjekshus J., Simonsen S., Bjornerheim R., Endresen K., and Hall C. Natriuretic peptides in patients with aortic stenosis. Am Heart J 142 (2001) 725-732
50. Haug C., Metzele A., Kochs M., Hombach V., and Grunert A. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol 16 (1993) 553-557
51. Onuoha G.N., Nicholls D.P., Patterson A., and Beringer T. Neuropeptide secretion in exercise. Neuropeptides 32 (1998) 319-325
52. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., Ogawa H., Okumura K., Mukoyama M., and Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
53. Bruneau B.G., and de Bold A.J. Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1. Cardiovasc Res 28 (1994) 1519-1525
54. Sudoh T., Kangawa K., Minamino N., and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78-81
55. Sawada Y., Suda M., Yokoyama H., Kanda T., Sakamaki T., Tanaka S., Nagai R., Abe S., and Takeuchi T. Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin. J Biol Chem 272 (1997) 20545-20554
56. Yan W., Wu F., Morser J., and Wu Q. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci U S A 97 (2000) 8525-8529
57. Gunning M., Ballermann B.J., Silva P., Brenner B.M., and Zeidel M.L. Brain natriuretic peptide: interaction with renal ANP system. Am J Physiol 258 (1990) F467-F472
58. Yandle T.G., Richards A.M., Gilbert A., Fisher S., Holmes S., and Espiner E.A. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 76 (1993) 832-838
59. Liang F., O'Rear J., Schellenberger U., Tai L., Lasecki M., Schreiner G.F., Apple F.S., Maisel A.S., Pollitt N.S., and Protter A.A. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 49 (2007) 1071-1078
60. Lam C.S., Burnett Jr. J.C., Costello-Boerrigter L., Rodeheffer R.J., and Redfield M.M. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 49 (2007) 1193-1202
61. Hawkridge A.M., Heublein D.M., Bergen III H.R., Cataliotti A., Burnett Jr. J.C., and Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 102 (2005) 17442-17447
62. Brandt I., Lambeir A.M., Ketelslegers J.M., Vanderheyden M., Scharpe S., and De Meester I. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin Chem 52 (2006) 82-87
63. Pankow K., Wang Y., Gembardt F., Krause E., Sun X., Krause G., Schultheiss H.P., Siems W.E., and Walther T. Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide. Circ Res 101 (2007) 875-882
64. Heublein D.M., Huntley B.K., Boerrigter G., Cataliotti A., Sandberg S.M., Redfield M.M., and Burnett Jr. J.C. Immunoreactivity and guanosine 3′,5′-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension 49 (2007) 1114-1119
65. Boerrigter G., Costello-Boerrigter L.C., Harty G.J., Lapp H., and Burnett Jr. J.C. Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation. Am J Physiol Regul Integr Comp Physiol 292 (2007) R897-R901
66. Seidler T., Pemberton C., Yandle T., Espiner E., Nicholls G., and Richards M. The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun 255 (1999) 495-501
67. Ala-Kopsala M., Magga J., Peuhkurinen K., Leipala J., Ruskoaho H., Leppaluoto J., and Vuolteenaho O. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50 (2004) 1576-1588
68. Schellenberger U., O'Rear J., Guzzetta A., Jue R.A., Protter A.A., and Pollitt N.S. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 451 (2006) 160-166
69. Lainchbury J.G., Nicholls M.G., Espiner E.A., Ikram H., Yandle T.G., and Richards A.M. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. Clin Sci (Lond) 95 (1998) 547-555
70. Richards A.M., Crozier I.G., Yandle T.G., Espiner E.A., Ikram H., and Nicholls M.G. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 69 (1993) 414-417
71. Schou M., Dalsgaard M.K., Clemmesen O., Dawson E.A., Yoshiga C.C., Nielsen H.B., Gustafsson F., Hildebrandt P.R., and Secher N.H. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 99 (2005) 1676-1680
72. Goetze J.P., Jensen G., Moller S., Bendtsen F., Rehfeld J.F., and Henriksen J.H. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 36 (2006) 8-15